CAS QIBEBT promotes duckweed as a bioremediation plant

The group of ZHOU Gongke at QIBEBT has used molecular biology, cell biology and bioinformatics and other research methods to elucidate the molecular biology of cadmium ion absorption, transport and detoxification in duckweed. The advantage of duckweed bioremediation...

BGI’s share value exceeds 100 billion Yuan

As a leading enterprise in China’s genetic testing industry, BGI combines strong R & D self-developed instruments and reagents to effectively control costs. The rapid growth of the reproductive and health businesses has formed a scale effect and BGI is active in...

China’s main cause of liver cancer is viral hepatitis

According to a national liver cancer clinical registration survey, 83 % of patients were male, and infection (58 %) and/or alcohol consumption was the main cause of disease. China Bio news release, November 14, 2017

5 Chinese companies among the global top 25 in market capitalization

According to a survey by Genetic Engineering News (GEN), the following 5 companies have entered the top 15 ranks: Sinopharm Holdings (24), Jiangsu Hengrui Pharmaceutical (13), Yunnan Baiyao Group (18), Kangmei Pharmaceutical (19) and Shanghai Fosun Pharmaceutical...

China has launched the „Pig Model Project“

Following an International Forum on Animal Biotechnology, the Chinese Academy of Engineering has announced that the country will launch the international pig model project (PMP, http://www.pigmodel.org). Organized by the Ministry of Science 
and Technology and...